Russian scientist pledges to make more CRISPR-edited babies
A Russian scientist is planning to create CRISPR-edited babies, despite the widespread condemnation levelled at the first scientist who created ‘edited’ twins.
Avocado company drops plant patent suit against rival
Dominican Republic-based Agroindustrial Ocoeña has asked a US court to dismiss its plant patent claim against a competitor run by the patent inventor’s brother.
India to make barcoding mandatory on all drugs
India is to make barcoding mandatory on all medicines sold within the country after a recent report by the Office of the US Trade Representative (USTR) identified the country as the largest producer of counterfeit pharmaceuticals in the world.
Merck strengthens immunotherapy expertise with $773m buy
US-based Merck & Co has announced plans to buy Tilos Therapeutics, its latest acquisition in the immunotherapy space.
USITC issues judgment in cholesterol testing strips dispute
The US International Trade Commission has issued a judgment after a surgical appliances company, Polymer Technology Systems (PTS), filed a complaint against a China-based competitor.
Eli Lilly petitions SCOTUS in $20m Cialis suit
Eli Lilly has asked the US Supreme Court to reconsider a lower court’s ruling which ordered the drugmaker to pay Germany-based Erfindergemeinschaft UroPep $20 million for patent infringement.
US patent reforms could re-establish gene patent eligibility, industry experts warn
A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.
EU General Court rejects lactic acid supplement TM
The EU’s General Court has upheld the European Union Intellectual Property Office’s finding that a trademark for dietary supplements was descriptive of the relevant services to an Italian speaking public.
Eli Lilly licenses AI tech for preclinical development
San Francisco-based biotech company Atomwise could be set to receive up to $1 million per target in milestone payments following a partnership agreement with Eli Lilly.
German court deals blow to Sanofi over cholesterol drug
A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.
